Christopher Eric Stone, President AEC at Albany International Corp., filed a Form 4 on August 13, 2026, disclosing the vesting of restricted stock units and the withholding of shares to cover related tax obligations, with transactions dated August 12, 2026 and March 1, 2026.
Fernando Adrian Elsztain, a director of Cresud Inc (NASDAQ:CRESY), filed a Form 4 on August 13, 2026, disclosing the sale of 10,000 common shares on August 12, 2026.
A Form 4 filed on August 13, 2026 discloses that Lisa A. Friel, a Director associated with Westlake Chemical Partners LP (NYSE:WLKP), reported the acquisition of 5,044 Phantom Units on August 12, 2026.
A Form 4 filed on August 13, 2026, reports that Stephen Finley, a director associated with Westlake Chemical Partners LP (NYSE:WLKP), acquired 5,044 Phantom Units on August 12, 2026.
A Form 4 filed on August 13, 2026 discloses that Randy Woelfel, a Director of Westlake Chemical Partners GP LLC, acquired 5,044 Phantom Units in Westlake Chemical Partners LP (NYSE:WLKP) on August 12, 2026.
Director Robert E. Mellor filed a Form 4 with the SEC on August 13, 2026, reporting the acquisition of restricted common stock of Monro, Inc. on August 11, 2026.
Gregory Warsek, Executive Vice President of Associated Banc-Corp, filed a Form 4 on August 13, 2026, reporting multiple transactions in the company's common stock dated August 12, 2026.
A Statement of Changes in Beneficial Ownership was filed on August 13, 2026, reporting a sale of Heritage Financial Corp common stock by Matthew T. Ray, Executive Vice President and Chief Lending Officer of the company.
Abeona Therapeutics Inc. filed a Form 8-K with the SEC on August 13, 2026, announcing the release of its financial results for the quarter ended June 30, 2026.
A Form 4 filed on August 13, 2026 reports that Daniel Mark Thau, a director of Blue Bird Corp, purchased 350 shares of common stock on August 12, 2026.